CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Matthew Abernethy

Chief Financial Officer, NEUROCRINE BIOSCIENCES INC

Verified interview transcripts, podcast appearances, and direct quotes from Matthew Abernethy, Chief Financial Officer at NEUROCRINE BIOSCIENCES INC. AI-verified speaker identity with full-text searchable transcripts.

Recent appearances

  • Once Upon A Gene - ONCE UPON A GENE –EPISODE 278: His Son Was Diagnosed with Congenital Adrenal...

    Effie welcomes Matt Abernethy, a father and biotech executive whose story feels almost too perfectly timed to be real. Matt’s youngest son, Ian (now 13), was diagnosed with classic congenital adrenal hyperplasia (CAH) at age two. While navigating the overwhelm, fear, and daily stress of managing a rare disease, Matt received a cold recruiter call for a CFO role at Neurocrine Biosciences — a company actively developing a treatment for CAH. He and his wife Brittany made the leap of faith, moving their family from Indiana to San Diego. Matt kept his personal connection private for years so he cou…

    Watch on YouTube ↗

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →